Tubo-on, Michael N.

HRN: 27-41-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2025
CO-AMOXICLAV 625MG (TAB)
07/04/2025
07/10/2025
PO
625mg
BID
Lacerated Wound, Frontal Area
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: